Unlock the Editor’s Digest without cost
Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication.
Temasek and Warburg Pincus are making ready to place healthcare provide chain administration firm World Healthcare Trade up on the market, aiming at a valuation of virtually $5bn, in accordance with individuals accustomed to the matter.
GHX, during which the Singaporean government-backed funding fund owns a majority stake and the US non-public fairness group the rest, was working with advisers on a sale course of, which might lead to a partial or full- stake sale, the individuals stated. GHX is anticipating to obtain formal bids within the second half of the 12 months.
The public sale is the newest instance of funding funds trying to offload property in a push to grasp returns on investments. Temasek has been invested within the firm since 2017, whereas Warburg Pincus purchased a minority stake in 2021.
By mid-March, non-public fairness teams had offloaded a complete of almost $119bn in property globally this 12 months, by way of gross sales or public listings. That is the second-highest stage in 20 years however nonetheless under the identical level in 2021 when a growth in sponsor-backed deal exercise resulted in $211bn of exits, in accordance with a Bain evaluation of Dealogic knowledge.
The GHX sale course of was probably to attract curiosity from non-public fairness teams in addition to strategic consumers, nevertheless it may not lead to a sale if the funds determined to carry on to the corporate, the individuals stated. GHX offers cloud-based stock, provide chain and cost administration companies for healthcare suppliers and suppliers.
Temasek and Warburg Pincus declined to remark. GHX declined to touch upon “hypothesis” concerning the sale course of, including that the corporate was “targeted on delivering modern provide chain options that enhance effectivity and cut back prices for healthcare suppliers and suppliers”.
This 12 months, non-public fairness teams have managed to engineer some giant exits from software program firms. Warburg Pincus, alongside members of the founding administration group, absolutely exited a 90 per cent stake in digital well being information firm Modernizing Drugs, promoting to Clearlake Capital in a deal that valued it at $5.3bn, with the non-public fairness group realising an almost 10-fold return on its funding, in accordance with individuals accustomed to the matter.
Thoma Bravo additionally struck a deal to promote vitality software program group Quorum to Francisco Companions for $2.4bn. Blackstone can be trying to exit digital well being information firm HealthEdge.
Temasek purchased a stake in GHX from Thoma Bravo in 2017, valuing the enterprise at $1.8bn. Warburg Pincus injected $500mn into the enterprise in 2021, at which level Thoma Bravo absolutely exited its stake.
Temasek has $291bn of property in its international funding portfolio, whereas Warburg Pincus has $87bn in property underneath administration.
